Avnet Files Form S-3 Shelf Registration Statement.Business Editors/High-Tech Writers PHOENIX--(BUSINESS WIRE)--Oct. 2, 2000 Avnet Inc. (NYSE NYSE See: New York Stock Exchange :AVT AVT avian arginine vasotocin. See vasotocin. ) filed a Form S-3 shelf registration statement with the Securities and Exchange Commission, which became effective on Sept. 29, 2000, pursuant to which it may issue up to $1.5 billion of debt or equity securities. The company intends initially to issue debt securities under the registration statement in order to help finance the previously announced $740 million (estimated) acquisition of EBV EBV Epstein-Barr virus. EBV abbr. Epstein-Barr virus Epstein-Barr virus (EBV) A virus in the herpes family that causes mononucleosis. , WBC WBC white blood cell; see leukocyte. WBC abbr. white blood cell WBC, n stands for white blood cell. , Atlas Europe and RKE RKE Remote Keyless Entry (car doors) Systems and to provide funds for increases in working capital to support additional growth in business. The company believes the amount of securities being registered will be sufficient to meet its capital needs for the foreseeable future. Phoenix-based Avnet Inc. is one of the world's largest distributors of semiconductors, interconnect, passive and electromechanical components and computer products from the industry's leading manufacturers. Serving customers in 60 countries, Avnet markets, inventories and adds value to these products and provides world-class supply-chain integration and engineering design services. A Fortune 500 company, Avnet's sales exceed $9 billion. The company's web site is located at www.avnet.com. |
|
||||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion